MyChesCo on MSN5h
Noramco Group Invests $25 Million to Expand Sterile Injectable Manufacturing
The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by ...
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
The expansion addresses US injectable capacity shortages and growing demand for reliable domestic sterile manufacturing.
Contract Pharma6d
The Noramco Group Invests $25M into Halo Pharma Facility in NJ
The Noramco Group is investing $25M into its Halo Pharma facility in Whippany, NJ to establish sterile injectable ...
Morningstar6d
The Noramco Group Invests $25 Million in Halo Pharma’s Whippany Facility to Offer Sterile Injectable Manufacturing
The investment includes the installation of a high-speed, state-of-the-art Groninger UFVN FlexFill syringe, cartridge, and vial filling line and a SKAN isolator to enhance production efficiency ...